FCRLA and infectious disease: Rostamzadeh et al. [32] also demonstrated that FCRL overexpression in B cell malignancies introduce them as logical candidates for the development of antibody- and cell-based immunotherapy approaches in B cell malignancies and immune-mediated and infectious diseases.